Structure of the azurin mutant nickel–Trp48Met from<i>Pseudomonas aeruginosa</i>at 2.2 Å resolution

L.‐C. Tsai(Chalmers University of Technology), Herbert Nar(Boehringer Ingelheim (Germany)), Nicklas Bonander(Chalmers University of Technology), Tore Vänngård, Christian Hammann(Max Planck Institute of Biochemistry), Göran Karlsson(Uppsala University), L. Sjölin, Vratislav Langer(Chalmers University of Technology)
Acta Crystallographica Section D Biological Crystallography
September 1, 1995
10.1107/s0907444995001041
Cited by 19

Related Papers

A specific antidote for dabigatran: functional and structural characterization
|Blood|2013|562
Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5·5 and pH 9·0
|Journal of Molecular Biology|1991|487
Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors
|Journal of Medicinal Chemistry|2002|454
Biophysics in drug discovery: impact, challenges and opportunities
|Nature Reviews Drug Discovery|2016|383
8-(3-(<i>R</i>)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a Highly Potent, Selective, Long-Acting, and Orally Bioavailable DPP-4 Inhibitor for the Treatment of Type 2 Diabetes
|Journal of Medicinal Chemistry|2007|285